Xtandi (enzalutamide) - Pfizer, Astellas
Ac-225 rosopatamab tetraxetan (CONV01-α) - Convergent Therapeutics
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04946370
 
Feb 4, 2026
 
Next